Prototypic and Arkypallidal Neurons in the Dopamine-Intact External Globus Pallidus

Autor: Abdi, Azzedine, Mallet, Nicolas, Mohamed, Foad Y, Sharott, Andrew, Dodson, Paul D, Nakamura, Kouichi C, Suri, Sana, Avery, Sophie V, Larvin, Joseph T, Garas, Farid N, Garas, Shady N, Vinciati, Federica, Morin, Stéphanie, Bezard, Erwan, Baufreton, Jérôme, Magill, Peter J

Publikováno v: Journal of Neuroscience
Journal of Neuroscience, Society for Neuroscience, 2015, 35 (17), pp.6667-88. ⟨10.1523/jneurosci.4662-14.2015⟩

International audience; Studies in dopamine-depleted rats indicate that the external globus pallidus (GPe) contains two main types of GABAergic projection cell; so-called "prototypic" and "arkypallidal" neurons. Here, we used correlative anatomical a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e2126d6714997106db87923e987ee7ee
https://europepmc.org/articles/PMC4412890/

Prototypic and arkypallidal neurons in the dopamine-intact external globus pallidus.

Autor: Abdi A; Université de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France., Mallet N; Université de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, Medical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and., Mohamed FY; Medical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and., Sharott A; Medical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and., Dodson PD; Medical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and Oxford Parkinson's Disease Centre, University of Oxford, Oxford OX1 3QX, United Kingdom., Nakamura KC; Medical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and., Suri S; Medical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and., Avery SV; Medical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and., Larvin JT; Medical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and., Garas FN; Medical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and., Garas SN; Medical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and., Vinciati F; Medical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and., Morin S; Université de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France., Bezard E; Université de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France., Baufreton J; Université de Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France, peter.magill@pharm.ox.ac.uk jerome.baufreton@u-bordeaux2.fr., Magill PJ; Medical Research Council Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom, and Oxford Parkinson's Disease Centre, University of Oxford, Oxford OX1 3QX, United Kingdom peter.magill@pharm.ox.ac.uk jerome.baufreton@u-bordeaux2.fr.

Publikováno v: The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2015 Apr 29; Vol. 35 (17), pp. 6667-88.